AbbVie Challenges Fairness Of Upcoming Testosterone Trials

As the lawsuits against testosterone makers continue to mount, AndroGel manufacturer AbbVie is raising questions about whether the process of picking the bellwether cases is fair enough.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news